Sinovac Biotech Ltd. (02493) proposes to elect Tang Chunshan, Liu Datao, Wu Hai, and Hua Jun as executive directors.
Meiwei Bio-B (02493) announced that the second board of directors was elected by the Annual General Meeting of Shareholders of the company for the year 2022 on April 27, 2023. The term of office for the second board of directors is from June 21, 2023 to June 20, 2026.
MiWei Biology -B (02493) announced that the second board of directors elected by the company's 2022 annual general meeting will take office on April 27, 2023. The term of the second board of directors will be from June 21, 2023 to June 20, 2026.
After qualification review and recommendation by the nomination committee, the board of directors proposed to elect Mr. Tang Chunshan, Dr. Liu Datao, Dr. Wu Hai, and Mr. Hua Jun as executive directors, and Mr. Qin Zhengyu, Mr. Zhou Rui, Ms. Li Fan, and Ms. Wang Fang as independent non-executive directors.
Dr. Gui Xun is an executive director (staff representative director), and will be the candidate for staff representative director of the labor union committee to be held at the temporary general meeting date. The election of staff representative directors does not require approval from the board of directors or shareholders.
Among the members of the second board of directors, Mr. Hu Huiguo will retire due to the expiration of his term and will no longer be a candidate for executive director, Mr. Wu Yufeng will retire and will no longer be a candidate for non-executive director, and Dr. Xu Qing and Dr. Zhao Qian will retire and will no longer be candidates for independent non-executive directors of the third board of directors. Therefore, Mr. Hu Huiguo will no longer serve as a member of the ESG committee, but will remain as the deputy general manager of the company. Dr. Xu Qing will no longer serve as a member of the audit committee, the remuneration and assessment committee, the nomination committee chairman, and the strategic committee member, and Dr. Zhao Qian will no longer serve as a member of the audit committee, the chairman of the remuneration and assessment committee, the member of the nomination committee, and the member of the ESG committee. The retirement of Mr. Hu Huiguo, Mr. Wu Yufeng, Dr. Xu Qing, and Dr. Zhao Qian will take effect after the new directors are elected at the temporary general meeting.
Related Articles

Sinolink: In June, the market will wait in volatility for the moment of validation.

GF SEC: Four switches behind the assets

CN Gold Review May PMI: Demand returns to contraction zone, industry differentiation expands.
Sinolink: In June, the market will wait in volatility for the moment of validation.

GF SEC: Four switches behind the assets

CN Gold Review May PMI: Demand returns to contraction zone, industry differentiation expands.






